Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hadean Ventures
Oslo, Oslo, Norway
- Ownership
- Private
- Employees
- ~8
- Development stage
- Other
01
Overview
Hadean Ventures is an active European life sciences venture capital firm investing in early-stage and scaling companies, with a focus on transformative healthcare innovation in biotech, pharma, medtech, diagnostics, and digital health. The firm is not a drug developer itself, but its portfolio spans several companies developing advanced therapeutics and technologies.
- Modalities
- Radioligand therapiesRNA-based therapiesDigital therapeuticsSynthetic biologyMedical devices
- Industry
- Investors
02
Partnerships
Portfolio company partnerships with pharma/biotech (e.g., Eli Lilly acquisition of Emergence Therapeutics)
Beyond the preview
Go deeper on Hadean Ventures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hadean Ventures.